Prostaglandin F_2α

ID: Reference9881

C₂₀H₃₄O₅

(5Z,9α,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid; (+-)-Pgf2-α; (+)-Prostaglandin F2a; (+)-Prostaglandin F2α; 9a,11a-PGF2; 9α,11α-PGF2; Amoglandin

12-Epileukotriene B4

ID: Reference9883

C₂₀H₃₂O₄

(5S,6Z,8E,10E,12S,14Z)-5,12-Dihydroxy-6,8,10,14-icosatetraenoic acid; 12(S)-Leukotriene B4; 12-epi-LTB4; 12S-LTB4; 2-epi-LTB4; (5S,6Z,8E,10E,12S,14Z)-5,12-Dihydroxyicosa-6,8,10,14-tetraenoic acid; [S-[R*,R*-(E,Z,E,Z)]]-5,12-Dihydroxy-6,8,10,14-eicosatetraenoate

1-(2,4-Difluorophenyl)-3-[(3S,5S)-1-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)-3-pyrrolidinyl]urea

ID: Reference9887

C₂₀H₁₉F₂N₅O₂

1-(2,4-Difluorophenyl)-3-[(3S,5S)-1-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]urea; Urea, N-(2,4-difluorophenyl)-N'-[(3S,5S)-1-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)-3-pyrrolidinyl]-; NAT18-383047

1-(4-Methoxyphenyl)-3-{(3S,5S)-1-methyl-5-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl}urea

ID: Reference9888

C₂₀H₂₂N₆O₃

1-(4-Methoxyphenyl)-3-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]urea; Urea, N-(4-methoxyphenyl)-N'-[(3S,5S)-1-methyl-5-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl]-; NAT18-355841

1-Benzyl-3-{(3S,5S)-1-methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl}urea

ID: Reference9889

C₂₀H₂₂N₆O₂

1-Benzyl-3-[(3S,5S)-1-methyl-5-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]urea; Urea, N-[(3S,5S)-1-methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl]-N'-(phenylmethyl)-; NAT18-355753

1-{(3S,5S)-1-Methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl}-3-phenylurea

ID: Reference9890

C₁₉H₂₀N₆O₂

1-[(3S,5S)-1-Methyl-5-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-3-phenylurea; Urea, N-[(3S,5S)-1-methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl]-N'-phenyl-; NAT18-355764

N-{(3S,5S)-1-Methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl}-8-quinolinesulfonamide

ID: Reference9891

C₂₁H₂₀N₆O₃S

N-[(3S,5S)-1-Methyl-5-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]quinoline-8-sulfonamide; 8-Quinolinesulfonamide, N-[(3S,5S)-1-methyl-5-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl]-; NAT18-355775

N-[(3S,5S)-1-Methyl-5-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-3-pyrrolidinyl]benzamide

ID: Reference9892

C₂₁H₁₉F₃N₄O₃

N-[(3S,5S)-1-Methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]benzamide; Benzamide, N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-3-pyrrolidinyl]-; NAT18-355399

4-(4-{5-[(2S)-1-(2-Fluorobenzyl)-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}-2-pyridinyl)morpholine

ID: Reference9900

C₂₂H₂₄FN₅O₂

4-[4-[5-[(2S)-1-[(2-Fluorophenyl)methyl]pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl]pyridin-2-yl]morpholine; Morpholine, 4-[4-[5-[(2S)-1-[(2-fluorophenyl)methyl]-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-; NAT18-428762

Auramine

ID: Reference9906

C₁₇H₂₁N₃

4,4'-Carbonimidoylbis(N,N-dimethylaniline); Auramine base; Auramine manufacture; Auramine N base; Auramine O base; Auramine O free base; Auramine oaf

12-Oxo leukotriene B4

ID: Reference9913

C₂₀H₃₀O₄

(5S,6Z,8E,10E,14Z)-5-Hydroxy-12-oxo-6,8,10,14-icosatetraenoic acid; 12-Dehydro-leukotriene B4; 12-Keto-leukotriene B4; 12-Keto-LTB4; 12-Oxo-LTB4; (5S,6Z,8E,10E,14Z)-5-Hydroxy-12-oxoeicosa-6,8,10,14-tetraenoic acid; (5S,6Z,8E,10E,14Z)-5-Hydroxy-12-oxoicosa-6,8,10,14-tetraenoate

Methylbutylnitrosamine

ID: Reference9915

C₅H₁₂N₂O

N-Methyl-N-nitroso-1-butanamine ; NMBA; MBNA; 1-Butanamine, N-methyl-N-nitroso-; Butanamine, N-methyl-N-nitroso-; Butylamine, N-methyl-N-nitroso-; Butylmethylnitrosamine